< Agent Blog
Sep
15
,
2022

New Call Recording and TPMO Disclaimer Requirement - Wellcare

September 15, 2022
Wellcare

Wellcare would like to inform you of new requirements for Third-Party Marketing Organizations (TPMO) resulting from a recent ruling made by the Centers for Medicare and Medicaid Services (CMS). All of the following new requirements go into effect October 1, 2022.

Please review the following sections to learn more about each new CMS requirement.

Telephonic Recordings

Beginning October 1, 2022, for all 2023 activities, all TPMOs, including all third-party marketing/lead generation vendors, agencies, 1099 agents and brokers (captive, independent street brokers, TeleDigital agents, etc.), will be required to record all beneficiary calls (sales, enrollment, administrative, etc.) – inbound and outbound – in their entirety, with no exception. Other important requirements:

  • Applies to all telephonic activities, even if it does not result in an enrollment.
  • Requirement applies to all beneficiaries and members. There is no distinction made between new and existing clients.
  • Consent to record must be obtained for all calls.
  • Recordings are not required for in-person activities.
  • Medicare requires all records be maintained for 10 years.

Remote Agent Telephonic Enrollment (RATE) through Ascend will be updated to include outbound call recording functionality. Recordings may be captured outside of Ascend but must comply with all relevant regulations and laws (consent, retention, producibility, etc.).

TPMO Disclaimer Language

Beginning October 1, 2022, the TPMO Disclaimer must be used by any TPMO that sells plans on behalf of more than one MA plan provider unless the TPMO sells all commercially available MA plans in a given service area. The disclaimer must be:

  • Verbally conveyed within the first minute of a sales call.
  • Electronically conveyed when communicating with a beneficiary through email, online chat, or other electronic means of communication (regardless of content).
  • Prominently displayed on TPMO websites (regardless of content).
  • Included in any marketing materials, including print materials and television advertisements, developed, used or distributed by the TPMO.

Lead Generation Activities

Beginning October 1, 2022, lead generating activities (either directly or indirectly) facilitated by a TPMO will need to include a notice to the beneficiary that their information may be shared with a licensed agent for future contact. The disclosure must be provided:

  • Verbally when communicating with a beneficiary through telephone.
  • In writing when communicating with a beneficiary through mail or other paper.
  • Electronically when communicating with a beneficiary through email, online chat, or other electronic messaging platform.
  • When beneficiary information is requested or collected (e.g., web forms, consent to contact, etc.), or a call transfer will take place.

Disclosure must also be made to the beneficiary that he or she is being transferred to a licensed agent who can enroll them into anew plan.

Oversight & Reporting

To fully comply with the new CMS requirements, TPMOs must:

  • Report to the plans monthly any staff disciplinary actions associated with beneficiary interaction.
  • Report all violations made by TPMOs of those rules that apply to the plans.
  • Make available all enrollment lead sources to the Plan upon request.
  • Disclose any subcontracted relationships used for marketing, lead generation, and enrollment

New 2023 TPME Contracts

As required by CMS, the 2023 Centene Third-Party Marketing Entity (TPME) contracts include the new TPMO contract requirements. No future action is needed if you have already signed the 2023 contract. In order to be considered Ready To Sell (RTS) with Centene/Wellcare, the 2023 Centene TPME contract must be signed.

The new contract updates relating to TPMO requirements include:

  • Disclosure of any subcontracted relationships used for marketing, lead generation, and enrollment.  
  • Requirement to record all beneficiary calls in their entirety.
  • Report to the plans monthly any staff disciplinary actions associated with beneficiary interaction.
  • Report all violations made by TPMOs of those rules that apply to the plans.
  • Applicable TPMO marketing disclaimer/disclosure.

View Details >View Details >

Questions? Call us at 855-888-8326.

Don't have a MedCareValue page yet?

Get Your FREE Site >

Posts you may be interested in...

Read More

Highmark Medicare Advantage: Important Update Regarding Buffalo Medical Group

November 20, 2024
Agent Blog Icon - Indicates this is a blog article.

Important Information Regarding Buffalo Medical Group

Read More

Coming soon: Unlimited hospital confinement coverage.

November 20, 2024
Agent Blog Icon - Indicates this is a blog article.

Available to sell November 25 in select states!

Read More

New proof of prior coverage requirement for Dental, Vision & Hearing applications

November 20, 2024
Agent Blog Icon - Indicates this is a blog article.

Proof of prior dental coverage required for waiting period waiver.

Read More

Cigna: Important message regarding D-SNP applications

November 18, 2024
Agent Blog Icon - Indicates this is a blog article.

Please review this important information.

Read More

Excellus BCBS Broker News Vol. 19 No. 11

November 18, 2024
Agent Blog Icon - Indicates this is a blog article.

Incorrect ID Card Mailing | Gag Clause | Healthy New York

Read More

UPMC For Life: Free tools and resources just for you!

November 18, 2024
Agent Blog Icon - Indicates this is a blog article.

As we approach the halfway point of AEP, it’s essential to keep the momentum going!

Who we are & what we do.

Choosing an FMO to work with is not just about having access to top insurance products and commissions, it’s about finding a one-on-one agent service that is prepared to meet your needs.  

Get to know us, and see how we can help you take your business to the next level.

Learn More

Helpful Links

New Here?

We love meeting new people! Fill out the form below, and one of our sales directors will get in touch with you shortly.

Thank you! Your form has been received!
Oops! Something went wrong while submitting the form